The tropism of SVV-001 for neuroendocrine cancer, mediated by upregulated TEM8/ANTXR1 can inform this paradigm and opens the door for novel uses of SVV-001 to target these tumor types. The gene discussed is ANTXR1; the disease is neuroendocrine carcinoma.